Difficulty: Medium
Average Score: 80%
Practice
Unwanted effect of plicamycin (formerly mithramycin) is:
Correct answer
B
Rationale
In the context of lifespan pharmacology, understanding the unwanted effects of medications is crucial for safe and effective patient care. In this case, the correct answer is B) Myelosuppression for plicamycin (formerly mithramycin). Myelosuppression refers to a decrease in the production of blood cells, leading to conditions like anemia, leukopenia, and thrombocytopenia. Plicamycin is known to have bone marrow suppressive effects, hence causing myelosuppression.
Option A) Diarrhea is an incorrect choice because it is not a common unwanted effect associated with plicamycin. Option C) Nephrolithiasis refers to kidney stone formation and is not a typical side effect of plicamycin. Option D) Metastatic calcifications are not a known adverse effect of plicamycin either.
Educationally, this question highlights the importance of recognizing and understanding the side effects of medications, especially in the context of pharmacological management across the lifespan. Healthcare professionals need to be able to anticipate, identify, and manage potential adverse effects to ensure patient safety and treatment efficacy. By knowing the specific unwanted effects of drugs like plicamycin, healthcare providers can monitor patients effectively and intervene promptly if needed.
Option A) Diarrhea is an incorrect choice because it is not a common unwanted effect associated with plicamycin. Option C) Nephrolithiasis refers to kidney stone formation and is not a typical side effect of plicamycin. Option D) Metastatic calcifications are not a known adverse effect of plicamycin either.
Educationally, this question highlights the importance of recognizing and understanding the side effects of medications, especially in the context of pharmacological management across the lifespan. Healthcare professionals need to be able to anticipate, identify, and manage potential adverse effects to ensure patient safety and treatment efficacy. By knowing the specific unwanted effects of drugs like plicamycin, healthcare providers can monitor patients effectively and intervene promptly if needed.